NCT07143799 Scalp Block Versus General Anesthesia in Patients Undergoing Evacuation of Subdural Hematoma Via Burr Hole
| NCT ID | NCT07143799 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Subdural Hematoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-08-11 |
| Primary Completion | 2026-03-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-08-11 with a primary completion date of 2026-03-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
this study amis to compare between Scalp block versus general anesthesia in patients undergoing evacuation of subdural hematoma via burr hole.
Eligibility Criteria
Inclusion Criteria * Age from 18 to 75 years old. * Both sexes. * American Society of Anesthesiologists (ASA) physical status II-III. * Patients with subdural hematoma undergoing burr-hole evacuation Exclusion Criteria: * Patients with a history of known sensitivity to study drugs. * Glasgow Coma Scale (GCS) \<8 * Impaired coagulation profile. * Any degree of heart block. * Infection at site of injection
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07143799 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Subdural Hematoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07143799 currently recruiting?
Yes, NCT07143799 is actively recruiting participants. Contact the research team at sakr422022@gmail.com for enrollment information.
Where is the NCT07143799 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT07143799 clinical trial?
NCT07143799 is sponsored by Sohag University. The trial plans to enroll 80 participants.